[
  {
    "ts": null,
    "headline": "A Look At Quest Diagnostics (DGX) Valuation After Recent Share Price Weakness",
    "summary": "Quest Diagnostics stock snapshot after recent performance Quest Diagnostics (DGX) has been on investors’ radars after a mixed stretch, with the share price showing a 0.6% decline over the past day and a 4.5% decline over the past week, alongside positive longer term returns. See our latest analysis for Quest Diagnostics. Viewed over a longer span, the recent 1 day and 7 day share price declines sit alongside a 1 month share price return of 2.9% and a 1 year total shareholder return of 15.3%...",
    "url": "https://finnhub.io/api/news?id=bd832480f609c966b31f07a037b5e0884689b2f4be4c4b46c1ac135a7202b081",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769444431,
      "headline": "A Look At Quest Diagnostics (DGX) Valuation After Recent Share Price Weakness",
      "id": 138263749,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Quest Diagnostics stock snapshot after recent performance Quest Diagnostics (DGX) has been on investors’ radars after a mixed stretch, with the share price showing a 0.6% decline over the past day and a 4.5% decline over the past week, alongside positive longer term returns. See our latest analysis for Quest Diagnostics. Viewed over a longer span, the recent 1 day and 7 day share price declines sit alongside a 1 month share price return of 2.9% and a 1 year total shareholder return of 15.3%...",
      "url": "https://finnhub.io/api/news?id=bd832480f609c966b31f07a037b5e0884689b2f4be4c4b46c1ac135a7202b081"
    }
  },
  {
    "ts": null,
    "headline": "How TEM Is Capitalizing on AI-Driven Pathology Market Growth",
    "summary": "Tempus AI boosts AI pathology reach by acquiring Paige and launching Paige Predict to deliver biomarker insights across 16 cancer types.",
    "url": "https://finnhub.io/api/news?id=535ba86c77fb58b9666e7b673fe39a7e52e5db60c8968c30e411f397dd92b09c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769438400,
      "headline": "How TEM Is Capitalizing on AI-Driven Pathology Market Growth",
      "id": 138263745,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Tempus AI boosts AI pathology reach by acquiring Paige and launching Paige Predict to deliver biomarker insights across 16 cancer types.",
      "url": "https://finnhub.io/api/news?id=535ba86c77fb58b9666e7b673fe39a7e52e5db60c8968c30e411f397dd92b09c"
    }
  },
  {
    "ts": null,
    "headline": "Guardant Health: Look For Explosive Revenue Growth Ahead",
    "summary": "Guardant Health: Look For Explosive Revenue Growth Ahead",
    "url": "https://finnhub.io/api/news?id=7899be8b188435bbb86a74c1713ed92da5f8e95ad28af031fefc8673f80f6bc6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769419901,
      "headline": "Guardant Health: Look For Explosive Revenue Growth Ahead",
      "id": 138261573,
      "image": "",
      "related": "DGX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=7899be8b188435bbb86a74c1713ed92da5f8e95ad28af031fefc8673f80f6bc6"
    }
  }
]